3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.77%
Negative revenue growth while M7U.DE stands at 21.29%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-22.70%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-59.22%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-58.79%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-62.10%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-62.07%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-62.07%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.81%
Dividend reduction while M7U.DE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
197.33%
OCF growth of 197.33% while M7U.DE is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
287.89%
FCF growth of 287.89% while M7U.DE is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.73%
3Y revenue/share CAGR under 50% of M7U.DE's 30.01%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-81.49%
Negative 3Y CAGR while M7U.DE is 35.45%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
75.09%
Below 50% of M7U.DE's 217.63%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-83.30%
Negative near-term dividend growth while M7U.DE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-17.68%
Firm’s AR is declining while M7U.DE shows 36.26%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-3.26%
Inventory is declining while M7U.DE stands at 7.95%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.30%
Negative asset growth while M7U.DE invests at 15.26%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.91%
BV/share growth above 1.5x M7U.DE's 1.19%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.83%
We’re deleveraging while M7U.DE stands at 26.19%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-5.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.